Richard Lipscombe
Managing Director & co-founder @ Proteomics International
Perth, Australia
Richard Lipscombe is a seed investor at Proteomics International in Perth focused on Medical and Health Care. Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research).
- Total investments:
- 1
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Richard Lipscombe invests in
Stages Richard Lipscombe invests in
Countries Richard Lipscombe invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Diag-Nose.io
|
Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments. The company is working on an affordable, rapid, and non-invasive self-test to determine the right treatment pathway for patients with acute sinusitis and to promote antibiotic stewardship for clinicians.Diag-Nose Medical flagshipproduct, the “RHINOSENSE” is a point-of-care test that combines non-invasive nasal sampling, lateral flow immunoassays, and host-immune markers to differentiate between viral, bacterial, and allergy mediated sinusitis. | $2M / Seed / Jan 30, 2025 |
Co-Investors
About Proteomics International
Proteomics International Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Richard Lipscombe
Managing Director & co-founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Richard Lipscombe invest in?
Richard Lipscombe invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Richard Lipscombe?
Public channels for Richard Lipscombe include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
